Immunotherapy of Nivolumab with Dendritic Cell Vaccination Is Effective against Intractable Recurrent Primary Central Nervous System Lymphoma: A Case Report

We report effective treatment with nivolumab of a patient with recurrent primary central nervous system lymphoma (PCNSL) after multiple therapies. A 41-year-old woman with a right parietal PCNSL underwent treatment with high-dose methotrexate and radiotherapy. After recurrence in the left frontal lo...

Descripción completa

Detalles Bibliográficos
Autores principales: FURUSE, Motomasa, NONOGUCHI, Naosuke, OMURA, Naoki, SHIRAHATA, Mitsuaki, IWASAKI, Koichi, INUI, Toshio, KUROIWA, Toshihiko, KUWABARA, Hiroko, MIYATAKE, Shin-Ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Neurosurgical Society 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409273/
https://www.ncbi.nlm.nih.gov/pubmed/28331101
http://dx.doi.org/10.2176/nmc.cr.2016-0330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409273/
https://www.ncbi.nlm.nih.gov/pubmed/28331101
http://dx.doi.org/10.2176/nmc.cr.2016-0330

Ejemplares similares